Cite
Marfo K, Aitken S, Akalin E. Clinical outcomes after conversion from brand-name tacrolimus (prograf) to a generic formulation in renal transplant recipients: a retrospective cohort study. P T. 2013;38(8):484-8
Marfo, K., Aitken, S., & Akalin, E. (2013). Clinical outcomes after conversion from brand-name tacrolimus (prograf) to a generic formulation in renal transplant recipients: a retrospective cohort study. P & T : a peer-reviewed journal for formulary management, 38(8), 484-8.
Marfo, Kwaku, et al. "Clinical outcomes after conversion from brand-name tacrolimus (prograf) to a generic formulation in renal transplant recipients: a retrospective cohort study." P & T : a peer-reviewed journal for formulary management vol. 38,8 (2013): 484-8.
Marfo K, Aitken S, Akalin E. Clinical outcomes after conversion from brand-name tacrolimus (prograf) to a generic formulation in renal transplant recipients: a retrospective cohort study. P T. 2013 Aug;38(8):484-8. PMID: 24222980; PMCID: PMC3814440.
Copy
Download .nbib